Forecast 2027, the HPV Testing and Pap Test Market is expected to reach US$ 9.2 billion at a CAGR of 13.2% | Abbott Laboratories (US), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US), Hologic, Inc. (US), Quest Diagnostics (US), Qiagen

According to the new market research report published by MarketsandMarkets, "HPV Testing and Pap Test Market Size, Growth by Test Type (HPV Testing (Follow-Up HPV Testing, Co- Testing, Primary HPV Testing), PAP Test), End User (Laboratories, Hospitals, Physician's Offices & Clinics), Region - Global Forecast to 2027", the global HPV testing and Pap test market in terms of revenue was estimated to be worth $4.9 billion in 2022 and is poised to reach $9.2 billion by 2027, growing at a CAGR of 13.2% from 2022 to 2027.

Browse in-depth TOC on "HPV Testing and Pap Test Market"
211 - Tables
35 - Figures
180 - Pages.

Download an Illustrative Overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371&utm_source=Openpr&utm_campaign=paid&utm_content=referral

Increased risk of HPV infections is the major factors driving the HPV testing and Pap test market's growth.

Based on test type, the HPV testing and Pap test market is segmented into HPV Testing and Pap Test. In 2021, the HPV testing segment accounted for the largest share of the HPV testing and Pap test market, mainly due to the rapid growth in number of cervical cancer cases.

Based on application, the HPV testing and Pap test market is segmented into cervical cancer screening and vaginal cancer screening. In 2021, the cervical cancer screening segment accounted for the largest share of the HPV testing and Pap test market, mainly due to introduction of primary HPV testing.
Based on end user, the HPV testing and Pap test market is segmented into laboratories, hospitals, and physician's offices & clinics. In 2021, the hospitals segment accounted for the largest share of the HPV testing and Pap test market. The large share of this segment can mainly be attributed to the growing concerns over spread of cancer.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=214207371&utm_source=Openpr&utm_campaign=paid&utm_content=referral

Geographical Growth Scenario:

The global HPV testing and Pap test market is segmented into five major regions-North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for HPV testing and Pap test market in 2021. The large share of North America in this market can be attributed to the favorable regulations.

Key Players:

The major players operating in this market are Abbott Laboratories (US), Roche Diagnostics (Switzerland), Becton, Dickinson and Company (US), Hologic, Inc. (US), Quest Diagnostics (US), Qiagen N.V. (Netherland), Seegene, Inc. (US), Femasys, Inc. (US), Arbor Vita Corporation (US) and Mylab Discovery Solutions Pvt. Ltd. (India).

Development of new cervical cancer diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the HPV testing and Pap test market.

Top HPV Testing and Pap Test Market Player:

Abbott Laboratories (US) held the leading position in the HPV testing and Pap test market. The company has maintained a leading position in the market through its strong presence across North America.he company also adopts organic growth strategies to increase its dominance in this market by innovating new products to increase the product range. The company has a wide distribution network spread across over 150 countries and 291 subsidaries.

Roche Diagnostics (Switzerland) held the second position in the HPV testing and Pap test market. It has a increased presence in North America, Europe and the Asia Pacific with a strong network and growth strategies. Roche focuses on increasing R&D with increased investment for innovation. The company has strong presence in North America and its major share comes from US.

Hologic, Inc. (US) held the leading position in the HPV testing and Pap market in 2021. Its leading position in this market can be attributed to its strong R&D investments. The company has strong presence globally due to excellent channel. The company increased its focus on R&D activities to develop unique products compared to its competitors. Company aims to develop and increase the women's health business competitiveness by delivering innovative solutions and technologies to its customers.

HPV Testing and Pap Test Market Report Objectives:

To define, describe, segment, and forecast the HPV testing and Pap test market by test type, end user and region.

To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges).

To analyse micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market.

To analyse market opportunities for stakeholders and provide details of the competitive landscape for key players.

To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa,

To profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies2.

To track and analyse company developments such as product launch, product approval, expansion, acquisition, collaboration in the HPV testing and Pap test market.

To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyses market players on various parameters within the broad categories of business and product strategy.

Request for assumptions & how numbers were triangulated.
https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371&utm_source=Openpr&utm_campaign=paid&utm_content=referral

Browse Related Reports:

https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html?utm_source=globenewswire&utm_medium=referral&utm_campaign=paidpr

https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html?utm_source=globenewswire&utm_medium=referral&utm_campaign=paidpr

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.